Ataxia telangiectasia mutated and Rad3 related ATR
Showing 1 - 25 of >10,000
NSCLC Trial in Pittsburgh (M1774, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
-
Pittsburgh, PennsylvaniaUPMC Cancer Center
May 22, 2023
Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)
Not yet recruiting
- Breast Cancer
- M1774
- Fulvestrant injection
-
Marseille, FranceInstitut Paoli Calmettes
Aug 9, 2023
Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- Elimusertib (BAY1895344)
- Pembrolizumab
-
Palo Alto, California
- +15 more
Jan 6, 2023
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell
Not yet recruiting
- Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +5 more
- Avelumab
- +6 more
- (no location specified)
Jul 13, 2023
Ataxia Telangiectasia Trial in Lørenskog, Oslo (Nicotinamide ribonucleoside)
Active, not recruiting
- Ataxia Telangiectasia
- Nicotinamide ribonucleoside
-
Lørenskog, Norway
- +1 more
Aug 16, 2022
Ataxia Telangiectasia in Children, Ataxia Telangiectasia Trial in Plymouth (Whole-body exercise and respiratory exercise)
Recruiting
- Ataxia Telangiectasia in Children
- Ataxia Telangiectasia
- Whole-body exercise and respiratory exercise
-
Plymouth, United KingdomUniversity of Plymouth
Jan 19, 2023
Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg
Active, not recruiting
- Metastatic Triple Negative Breast Cancer
- Olaparib Continuous (28-Day cycle) 300 mg BD.
- +2 more
-
Birmingham, Alabama
- +140 more
Nov 17, 2022
Pilot Study of Pancreatic Cancer Screening
Recruiting
- Pancreatic Carcinoma
- Biospecimen Collection
- +4 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Apr 13, 2022
Metastasis, Locally Advanced Solid Tumor, Recurrent Cancer Trial in Stanford, New York (XRD-0394, Palliative radiotherapy)
Recruiting
- Metastasis
- +2 more
- XRD-0394
- Palliative radiotherapy
-
Stanford, California
- +1 more
Sep 27, 2021
Prostate Carcinoma Metastatic to the Bone, Stage IV Prostate Adenocarcinoma, Hormone-refractory Prostate Cancer Trial in United
Active, not recruiting
- Prostate Carcinoma Metastatic to the Bone
- +2 more
- Niraparib
- Radium Ra 223 Dichloride
-
Birmingham, Alabama
- +5 more
Feb 10, 2021
Ataxia Telangiectasia Louis-Bar, Ataxia Telangiectasia in Children, Ataxia Telangiectasia Trial in Houston (MBM-01)
Not yet recruiting
- Ataxia Telangiectasia Louis-Bar
- +2 more
-
Houston, TexasUniversity of Texas Health Science Center at Houston
May 13, 2021
Eye Movement Activity in an Ataxia Telangiectasia
Completed
- Ataxia Telangiectasia
- Dysmetria
-
Chéjov, Russian FederationClinical Rehabilitation Research Center "Russkoe pole"
Jul 20, 2022
Leukemia and Lymphoma in Children With Ataxia Telangiectasia
Recruiting
- Ataxia Telangiectasia
- +2 more
-
Petah Tikva, IsraelSchneider Children's Medical Center
Sep 30, 2021
Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)
Completed
- Refractory Cancer
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Ataxia Telangiectasia Trial in Frankfurt (Lumbar puncture)
Completed
- Ataxia Telangiectasia
- Lumbar puncture
-
Frankfurt, Hessen, GermanyJohann Wolfgang Goethe University Hospitals
Aug 30, 2021
Ataxia Telangiectasia, ATM Gene Mutation Trial in Nijmegen (Vitamin B3)
Completed
- Ataxia Telangiectasia
- ATM Gene Mutation
- Vitamin B3
-
Nijmegen, NetherlandsRadboudumc
Jul 21, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +6 more
- (no location specified)
Jan 14, 2023
Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Kraków, Poland
- +10 more
Dec 2, 2022
Ovarian Cancer Recurrent Trial in Birmingham (M4344+Niraparib)
Not yet recruiting
- Ovarian Cancer Recurrent
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 5, 2023